Epithelial-mesenchymal transition as a mechanism of metastasis

Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice

Volumn , Issue , 2009, Pages 65-92

  Savary, Katia ^a   Termén, Stefan ^a   Thuault, Sylvie ^a   Keshamouni, Venkateshwar ^b   Moustakas, Aristidis ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900661888     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-0772-1_4     Document Type: Chapter

References (170)

1. Hay, E.D. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev. Dyn. 233: 706-720, 2005.
2. Berx, G., E. Raspe, G. Christofori, J.P. Thiery, and J.P. Sleeman. Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clin. Exp. Metastasis 24: 587-597, 2007.
3. Hugo, H., M.L. Ackland, T. Blick, M.G. Lawrence, J.A. Clements, E.D. Williams, and E.W. Thompson. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J. Cell. Physiol. 213: 374-383, 2007.
4. Zeisberg, M. and R. Kalluri. The role of epithelial-to-mesenchymal transition in renal fibrosis. J. Mol. Med. 82: 175-181, 2004.
5. Radisky, D.C., P.A. Kenny, and M.J. Bissell. Fibrosis and cancer: Do myofibroblasts come also from epithelial cells via EMT? J. Cell. Biochem. 101: 830-839, 2007.
6. Zeisberg, E.M., S. Potenta, L. Xie, M. Zeisberg, and R. Kalluri. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 67: 10123-10128, 2007.
7. Huber, M.A., N. Kraut, and H. Beug. Molecular requirements for epithelial-mesench-ymal transition during tumor progression. Curr. Opin. Cell Biol. 17: 548-558, 2005.
8. Moustakas, A. and C.-H. Heldin. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 98: 1512-1520, 2007.
9. Peinado, H., D. Olmeda, and A. Cano. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer 7: 415-428, 2007.
10. Keller, R., L. Davidson, A. Edlund, T. Elul, M. Ezin, D. Shook, and P. Skoglund. Mechanisms of convergence and extension by cell intercalation. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 355: 897-922, 2000.
11. Deng, C.-X., A. Wynshaw-Boris, M.M. Shen, C. Daugherty, D.M. Ornitz, and P.Leder. Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev. 8: 3045-3057, 1994.
12. Yamaguchi, T.P., K. Harpal, M. Henkemeyer, and J. Rossant. fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev. 8: 3032-3044, 1994.
13. Sun, X., E.N. Meyers, M. Lewandoski, and G.R. Martin. Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. Genes Dev. 13: 1834-1846, 1999.
14. Batlle, E., E. Sancho, C. Franci, D. Dominguez, M. Monfar, J. Baulida, and A. Garcia De Herreros. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2: 84-89, 2000.
15. Cano, A., M.A. Perez-Moreno, I. Rodrigo, A. Locascio, M.J. Blanco, M.G. del Barrio, F. Portillo, and M.A. Nieto. The transcription factor snail controls epithelial-mesench-ymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2: 76-83, 2000.
16. Ciruna, B. and J. Rossant. FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev. Cell 1: 37-49, 2001.
17. Sheng, G., M. dos Reis, and C.D. Stern. Churchill, a zinc finger transcriptional activator, regulates the transition between gastrulation and neurulation. Cell 115: 603-613, 2003.
18. Carver, E.A., R. Jiang, Y. Lan, K.F. Oram, and T. Gridley. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol. Cell. Biol. 21: 8184-8188, 2001.
19. Takada, S., K.L. Stark, M.J. Shea, G. Vassileva, J.A. McMahon, and A.P. McMahon. Wnt-3a regulates somite and tailbud formation in the mouse embryo. Genes Dev. 8: 174-189, 1994.
20. Galceran, J., S.C. Hsu, and R. Grosschedl. Rescue of a Wnt mutation by an activated form of LEF-1: regulation of maintenance but not initiation of Brachyury expression. Proc. Natl. Acad. Sci. USA 98: 8668-8673, 2001.
21. Barrallo-Gimeno, A. and M.A. Nieto. Evolution of the neural crest. Adv. Exp. Med. Biol. 589: 235-244, 2006.
22. LaBonne, C., and M. Bronner-Fraser. Induction and patterning of the neural crest, a stem cell-like precursor population. J. Neurobiol. 36: 175-189, 1998.
23. Kalcheim, C. Mechanisms of early neural crest development: from cell specification to migration. Int. Rev. Cytol. 200: 143-196, 2000.
24. Halloran, M.C. and J.D. Berndt. Current progress in neural crest cell motility and migration and future prospects for the zebrafish model system. Dev. Dyn. 228: 497-513, 2003.
25. LaBonne, C. and M. Bronner-Fraser. Snail-related transcriptional repressors are required in Xenopus for both the induction of the neural crest and its subsequent migration. Dev. Biol. 221: 195-205, 2000.
26. Nawshad, A., D. LaGamba, and E.D. Hay. Transforming growth factor b (TGFb) signalling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT). Arch. Oral Biol. 49: 675-689, 2004.
27. Murray, S.A., K.F. Oram, and T. Gridley. Multiple functions of Snail family genes during palate development in mice. Development 134: 1789-1797, 2007.
28. Person, A.D., S.E. Klewer, and R.B. Runyan. Cell biology of cardiac cushion development. Int. Rev. Cytol. 243: 287-335, 2005.
29. Zavadil, J., L. Cermak, N. Soto-Nieves, and E.P. Bottinger. Integration of TGF-b/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 23: 1155-1165, 2004.
30. Niimi, H., K. Pardali, M. Vanlandewijck, C.-H. Heldin, and A. Moustakas. Notch signaling is necessary for epithelial growth arrest by TGF-b. J. Cell Biol. 176: 695-707, 2007.
31. Chuang, P.T. and A.P. McMahon. Branching morphogenesis of the lung: new molecular insights into an old problem. Trends Cell Biol. 13: 86-91, 2003.
32. Shannon, J.M. Induction of alveolar type II cell differentiation in fetal tracheal epithelium by grafted distal lung mesenchyme. Dev. Biol. 166: 600-614, 1994.
33. Cardoso, W.V. and J. Lu. Regulation of early lung morphogenesis: questions, facts and controversies. Development 133: 1611-1624, 2006.
34. Min, H., D.M. Danilenko, S.A. Scully, B. Bolon, B.D. Ring, J.E. Tarpley, M. DeRose, and W.S. Simonet. Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. Genes Dev. 12: 3156-3161, 1998.
35. Sekine, K., H. Ohuchi, M. Fujiwara, M. Yamasaki, T. Yoshizawa, T. Sato, N. Yagishita, D. Matsui, Y. Koga, N. Itoh, and S. Kato. Fgf10 is essential for limb and lung formation. Nat. Genet. 21: 138-141, 1999.
36. Weaver, M., N.R. Dunn, and B.L. Hogan. Bmp4 and Fgf10 play opposing roles during lung bud morphogenesis. Development 127: 2695-2704, 2000.
37. Cardoso, W.V., A. Itoh, H. Nogawa, I. Mason, and J.S. Brody. FGF-1 and FGF-7 induce distinct patterns of growth and differentiation in embryonic lung epithelium. Dev. Dyn. 208: 398-405, 1997.
38. Kaartinen, V., J.W. Voncken, C. Shuler, D. Warburton, D. Bu, N. Heisterkamp, and J. Groffen. Abnormal lung development and cleft palate in mice lacking TGF-b 3 indicates defects of epithelial-mesenchymal interaction. Nat. Genet. 11: 415-421, 1995.
39. Serra, R., R.W. Pelton, and H.L. Moses. TGF b1 inhibits branching morphogenesis and N-myc expression in lung bud organ cultures. Development 120: 2153-2161, 1994.
40. Zhou, L., C.R. Dey, S.E. Wert, and J.A. Whitsett. Arrested lung morphogenesis in transgenic mice bearing an SP-C-TGF-b 1 chimeric gene. Dev. Biol. 175: 227-238, 1996.
41. Zhao, J., D. Bu, M. Lee, H.C. Slavkin, F.L. Hall, and D. Warburton. Abrogation of transforming growth factor-b type II receptor stimulates embryonic mouse lung branching morphogenesis in culture. Dev. Biol. 180: 242-257, 1996.
42. Zhao, J., M. Lee, S. Smith, and D. Warburton. Abrogation of Smad3 and Smad2 or of Smad4 gene expression positively regulates murine embryonic lung branching morphogenesis in culture. Dev. Biol. 194: 182-195., 1998.
43. Bitgood, M.J. and A.P. McMahon. Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev. Biol. 172: 126-138, 1995.
44. Bellusci, S., R.Henderson, G.Winnier, T.Oikawa, and B.L. Hogan. Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis. Development 122: 1693-1702, 1996.
45. Hogan, B.L. Morphogenesis. Cell 96: 225-233., 1999.
46. Murone, M., A. Rosenthal, and F.J. de Sauvage. Sonic hedgehog signaling by the patched-smoothened receptor complex. Curr. Biol. 9: 76-84, 1999.
47. Litingtung, Y., L. Lei, H. Westphal, and C. Chiang. Sonic hedgehog is essential to foregut development. Nat. Genet. 20: 58-61, 1998.
48. Pepicelli, C.V., P.M. Lewis, and A.P. McMahon. Sonic hedgehog regulates branching morphogenesis in the mammalian lung. Curr. Biol. 8: 1083-1086, 1998.
49. Bellusci, S., Y. Furuta, M.G. Rush, R. Henderson, G. Winnier, and B.L. Hogan. Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis. Development 124: 53-63, 1997.
50. Motoyama, J., H. Heng, M.A. Crackower, T. Takabatake, K. Takeshima, L.C. Tsui, and C. Hui. Overlapping and non-overlapping Ptch2 expression with Shh during mouse embryogenesis. Mech. Dev. 78: 81-84, 1998.
51. Grindley, J.C., S. Bellusci, D. Perkins, and B.L. Hogan. Evidence for the involvement of the Gli gene family in embryonic mouse lung development. Dev. Biol. 188: 337-348, 1997.
52. Threadgill, D.W., A.A. Dlugosz, L.A. Hansen, T. Tennenbaum, U. Lichti, D. Yee, C. LaMantia, T. Mourton, K. Herrup, R.C. Harris, et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269: 230-234, 1995.
53. Miettinen, P.J., D. Warburton, D. Bu, J.S. Zhao, J.E. Berger, P. Minoo, T. Koivisto, L. Allen, L. Dobbs, Z. Werb, and R. Derynck. Impaired lung branching morphogenesis in the absence of functional EGF receptor. Dev. Biol. 186: 224-236, 1997.
54. Leveen, P., M. Pekny, S. Gebre-Medhin, B. Swolin, E. Larsson, and C. Betsholtz. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8: 1875-1887, 1994.
55. Aranda, V., T. Haire, M.E. Nolan, J.P. Calarco, A.Z. Rosenberg, J.P. Fawcett, T. Pawson, and S.K. Muthuswamy. Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. Nat. Cell Biol. 8: 1235-1245, 2006.
56. Carraway, C.A. and K.L. Carraway. Sequestration and segregation of receptor kinases in epithelial cells: implications for ErbB2 oncogenesis. Sci. STKE 2007: re3, 2007.
57. Rosario, M. and W. Birchmeier. How to make tubes: signaling by the Met receptor tyrosine kinase. Trends Cell Biol. 13: 328-335, 2003.
58. Schramek, H., E. Feifel, E. Healy, and V. Pollack. Constitutively active mutant of the mitogen-activated protein kinase kinase MEK1 induces epithelial dedifferentiation and growth inhibition in madin-darby canine kidney-C7 cells. J. Biol. Chem. 272: 11426-11433, 1997.
59. Montesano, R., J.V. Soriano, G. Hosseini, M.S. Pepper, andH. Schramek. Constitutively active mitogen-activated protein kinase kinase MEK1 disrupts morphogenesis and induces an invasive phenotype in Madin-Darby canine kidney epithelial cells. Cell Growth Differ. 10: 317-332, 1999.
60. Lehmann, K., E. Janda, C.E. Pierreux, M. Rytomaa, A. Schulze, M. McMahon, C.S. Hill, H. Beug, and J. Downward. Raf induces TGFb production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev. 14: 2610-2622, 2000.
61. Janda, E., K.Lehmann, I. Killisch, M. Jechlinger, M.Herzig, J. Downward, H.Beug, and S. Grunert. Ras and TGFb cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156: 299-313., 2002.
62. Oft, M., R.J. Akhurst, and A. Balmain. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat. Cell Biol. 4: 487-494., 2002.
63. Grotegut, S., D. von Schweinitz, G. Christofori, and F. Lehembre. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. Embo J 25: 3534-45, 2006.
64. Savagner, P., K.M. Yamada, and J.P. Thiery. The zinc-finger protein slug causes desmo-some dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J. Cell Biol. 137: 1403-1419, 1997.
65. Cordenonsi, M., M. Montagner, M. Adorno, L. Zacchigna, G. Martello, A. Mamidi, S. Soligo, S. Dupont, and S. Piccolo. Integration of TGF-b and Ras/MAPK signaling through p53 phosphorylation. Science 315: 840-843, 2007.
66. Irie, H.Y., R.V. Pearline, D. Grueneberg, M. Hsia, P. Ravichandran, N. Kothari, S. Natesan, and J.S. Brugge. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J. Cell Biol. 171: 1023-1034, 2005.
67. Larue, L. and A. Bellacosa.Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene 24: 7443-7454, 2005.
68. Zohn, I.E., Y. Li, E.Y. Skolnik, K.V. Anderson, J. Han, and L. Niswander. p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation. Cell 125: 957-69, 2006.
69. Oft, M., K.H. Heider, and H. Beug. TGFbsignaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol. 8: 1243-1252., 1998.
70. Portella, G., S.A. Cumming, J. Liddell, W. Cui, H. Ireland, R.J. Akhurst, and A. Balmain. Transforming growth factor b is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ. 9: 393-404., 1998.
71. Gotzmann, J., H. Huber, C. Thallinger, M. Wolschek, B. Jansen, R. Schulte-Hermann, H. Beug, and W. Mikulits. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-b1 and Ha-Ras: steps towards invasiveness. J. Cell Sci. 115: 1189-1202, 2002.
72. Miettinen, P.J., R. Ebner, A.R. Lopez, and R. Derynck. TGF-b induced transdifferentia-tion of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol. 127: 2021-2036., 1994.
73. Valcourt, U., M. Kowanetz, H. Niimi, C.-H. Heldin, and A. Moustakas. TGF-b and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol. Biol. Cell 16: 1987-2002, 2005.
74. Willis, B.C., J.M. Liebler, K. Luby-Phelps, A.G. Nicholson, E.D. Crandall, R.M. du Bois, and Z. Borok. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-b1: potential role in idiopathic pulmonary fibrosis. Am. J. Pathol. 166: 1321-1332, 2005.
75. Bierie, B. and H.L. Moses.: Tumour microenvironment: TGFb the molecular Jekyll and Hyde of cancer. Nat. Rev. Cancer 6: 506-520, 2006.
76. Yang, Y., X. Pan, W. Lei, J. Wang, and J. Song. Transforming growth factor-b1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism. Oncogene 25: 7235-7244, 2006.
77. Sakaue-Sawano, A., H. Kurokawa, T. Morimura, A. Hanyu, H. Hama, H. Osawa, S. Kashiwagi, K. Fukami, T. Miyata, H. Miyoshi, T. Imamura, M. Ogawa, H. Masai, and A. Miyawaki. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132: 487-498, 2008.
78. Massague, J., J. Seoane, and D. Wotton. Smad transcription factors. Genes Dev. 19: 2783-2810, 2005.
79. Piek, E., A. Moustakas, A. Kurisaki, C.-H. Heldin, and P. ten Dijke. TGF-b type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentia-tion in NMuMG breast epithelial cells. J. Cell Sci. 112: 4557-4568, 1999.
80. Kowanetz, M., U. Valcourt, R. Bergstrom, C.-H. Heldin, and A. Moustakas. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor b and bone morphogenetic protein. Mol. Cell. Biol. 24: 4241-4254, 2004.
81. Pardali, K. and A. Moustakas. Actions of TGF-b as tumor suppressor and pro-meta-static factor in human cancer. Biochim. Biophys. Acta 1775: 21-62, 2007.
82. Takano, S., F.Kanai, A. Jazag, H.Ijichi, J.Yao, H. Ogawa, N. Enomoto, M.Omata, and A. Nakao. Smad4 is Essential for Down-regulation of E-cadherin Induced by TGF-b in Pancreatic Cancer Cell Line PANC-1. J. Biochem. (Tokyo) 141: 345-351, 2007.
83. Li, W., W. Qiao, L. Chen, X. Xu, X. Yang, D. Li, C. Li, S.G. Brodie, M.M. Meguid, L. Hennighausen, and C.-X. Deng. Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice. Development 130: 6143-6153, 2003.
84. Bardeesy, N., K.H. Cheng, J.H. Berger, G.C. Chu, J. Pahler, P. Olson, A.F. Hezel, J. Horner, G.Y. Lauwers, D. Hanahan, and R.A. DePinho. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 20: 3130-3146, 2006.
85. Deckers, M., M. van Dinther, J. Buijs, I. Que, C. Lowik, G. van der Pluijm, and P. ten Dijke. The tumor suppressor Smad4is required for transforming growth factor b-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res. 66: 2202-2209, 2006.
86. Ju, W., A. Ogawa, J. Heyer, D. Nierhof, L. Yu, R. Kucherlapati, D.A. Shafritz, and E.P. Bottinger. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol. Cell. Biol. 26: 654-667, 2006.
87. Phanish, M.K., N.A. Wahab, P. Colville-Nash, B.M. Hendry, and M.E. Dockrell. The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFb1 responses in human proximal-tubule epithelial cells. Biochem J. 393: 601-607, 2006.
88. Zavadil, J. and E.P. Bottinger. TGF-b and epithelial-to-mesenchymal transitions. Onco-gene 24: 5764-5774, 2005.
89. Moustakas, A. and C.-H. Heldin. Non-Smad TGF-b signals. J. Cell Sci. 118: 3573-3584, 2005.
90. Yang, Y., X. Pan, W. Lei, J. Wang, J. Shi, F. Li, and J. Song. Regulation of Transforming Growth Factor-b1-Induced Apoptosis and Epithelial-to- Mesenchymal Transition by Protein Kinase A and Signal Transducers and Activators of Transcription 3. Cancer Res. 66: 8617-8624, 2006.
91. Bhowmick, N.A., R. Zent, M. Ghiassi, M. McDonnell, and H.L. Moses. Integrin b1 signaling is necessary for transforming growth factor-b activation of p38 MAPK and epithelial plasticity. J. Biol. Chem. 276: 46707-713, 2001.
92. Bates, R.C., D.I. Bellovin, C. Brown, E. Maynard, B. Wu, H. Kawakatsu, D. Sheppard, P. Oettgen, and A.M. Mercurio. Transcriptional activation of integrin b6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J. Clin. Invest. 115: 339-347, 2005.
93. Li, Y., J. Yang, C. Dai, C. Wu, and Y. Liu. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J. Clin. Invest. 112: 503-516, 2003.
94. Lee, Y.I., Y.J. Kwon, and C.K. Joo. Integrin-linked kinase function is required for transforming growth factor b-mediated epithelial to mesenchymal transition. Biochem. Biophys. Res. Commun. 316: 997-1001, 2004.
95. Shim, J.H., C. Xiao, A.E. Paschal, S.T. Bailey, P. Rao, M.S. Hayden, K.Y. Lee, C. Bussey, M. Steckel, N. Tanaka, G. Yamada, S. Akira, K. Matsumoto, and S. Ghosh. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19: 2668-2681, 2005.
96. Zavadil, J., M. Bitzer, D. Liang, Y.C. Yang, A. Massimi, S. Kneitz, E. Piek, and E.P. Bottinger. Genetic programs of epithelial cell plasticity directed by transforming growth factor-b. Proc. Natl. Acad. Sci. USA 98: 6686-6691, 2001.
97. Jechlinger, M., S. Grunert, I.H. Tamir, E. Janda, S. Ludemann, T. Waerner, P. Seither, A. Weith, H. Beug, and N. Kraut. Expression profiling of epithelial plasticity in tumor progression. Oncogene 22: 7155-7169, 2003.
98. Kang, Y., P.M. Siegel, W. Shu, M. Drobnjak, S.M. Kakonen, C. Cordon-Cardo, T.A. Guise, and J. Massague. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549, 2003.
99. Xie, L., B.K. Law, M.E. Aakre, M.Edgerton, Y. Shyr, N.A. Bhowmick, and H.L. Moses. Transforming growth factor b-regulated gene expression in a mouse mammary gland epithelial cell line. Breast Cancer Res. 5: R187-198, 2003.
100. LaGamba, D., A. Nawshad, and E.D. Hay. Microarray analysis of gene expression during epithelial-mesenchymal transformation. Dev. Dyn. 234: 132-142, 2005.
101. Barrallo-Gimeno, A. and M.A. Nieto. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132: 3151-3161, 2005.
102. Shen, X., J. Li, P.P. Hu, D. Waddell, J. Zhang, and X.-F. Wang. The activity of guanine exchange factor NET1 is essential for transforming growth factor-b-mediated stress fiber formation. J. Biol. Chem. 276: 15362-15368., 2001.
103. Bakin, A.V., A. Safina, C. Rinehart, C. Daroqui, H. Darbary, and D.M. Helfman. A critical role of tropomyosins in TGF-b regulation of the actin cytoskeleton and cell motility in epithelial cells. Mol. Biol. Cell 15: 4682-4694, 2004.
104. Peinado, H., M. Quintanilla, and A. Cano. Transforming growth factor b-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J. Biol. Chem. 278: 21113-21123, 2003.
105. Sato, M., Y. Muragaki, S. Saika, A.B. Roberts, and A. Ooshima. Targeted disruption of TGF-b1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J. Clin. Invest. 112: 1486-1494, 2003.
106. Thuault, S., U. Valcourt, M. Petersen, G. Manfioletti, C.-H. Heldin, and A. Moustakas. Transforming growth factor-b employs HMGA2 to elicit epithelial-mesenchymal transition. J. Cell Biol. 174: 175-183, 2006.
107. Kondo, M., E.Cubillo, K.Tobiume, T.Shirakihara, N. Fukuda, H. Suzuki, K. Shimizu, K. Takehara, A. Cano, M. Saitoh, and K. Miyazono. A role for Id in the regulation of TGF-b-induced epithelial-mesenchymal transdifferentiation. Cell Death Differ. 11: 1092-1101, 2004.
108. Kang, Y., C.R. Chen, and J.Massague.Aself-enabling TGFb response coupled to stress signaling. Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell 11: 915-926, 2003.
109. Zeisberg, M., A.A. Shah, andR. Kalluri. Bone morphogenic protein-7 induces mesench-ymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J. Biol. Chem. 280: 8094-8100, 2005.
110. Saika, S., K. Ikeda, O. Yamanaka, K.C. Flanders, Y. Ohnishi, Y. Nakajima, Y. Muragaki, and A. Ooshima. Adenoviral gene transfer of BMP-7, Id2, or Id3 suppresses injury-induced epithelial-to-mesenchymal transition of lens epithelium in mice. Am. J. Physiol. Cell Physiol. 290: C282-C289, 2006.
111. Comijn, J., G. Berx, P. Vermassen, K. Verschueren, L. van Grunsven, E. Bruyneel, M. Mareel, D. Huylebroeck, and F. van Roy. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 7: 1267-1278., 2001.
112. Peinado, H., F. Portillo, and A. Cano. Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol. 48: 365-375, 2004.
113. Vandewalle, C., J. Comijn, B. De Craene, P. Vermassen, E. Bruyneel, H. Andersen, E. Tulchinsky, F. Van Roy, and G. Berx. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 33: 6566-6578, 2005.
114. Eger, A., A. Stockinger, J. Park, E. Langkopf, M. Mikula, J. Gotzmann, W. Mikulits, H. Beug, and R. Foisner. b-Catenin and TGFb signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Oncogene 23: 2672-2680, 2004.
115. Martinez-Alvarez, C., M.J. Blanco, R. Perez, M.A. Rabadan, M. Aparicio, E. Resel, T. Martinez, and M.A. Nieto. Snail family members and cell survival in physiological and pathological cleft palates. Dev. Biol. 265: 207-218, 2004.
116. Li, Y., J. Yang, J.H. Luo, S. Dedhar, and Y. Liu. Tubular epithelial cell dedifferentiation is driven by the helix-loop-helix transcriptional inhibitor Id1. J. Am. Soc. Nephrol. 18: 449-460, 2007.
117. Mani, S.A., J. Yang, M. Brooks, G. Schwaninger, A. Zhou, N. Miura, J.L. Kutok, K. Hartwell, A.L. Richardson, and R.A. Weinberg. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc. Natl. Acad. Sci. USA 104: 10069-10074, 2007.
118. Venkov, C.D., A.J. Link, J.L. Jennings, D. Plieth, T. Inoue, K. Nagai, C. Xu, Y.N. Dimitrova, F.J. Rauscher, and E.G. Neilson. A proximal activator of transcription in epithelial-mesenchymal transition. J. Clin. Invest. 117: 482-491, 2007.
119. Spira, A. and D.S. Ettinger. Multidisciplinary management of lung cancer. N. Engl. J. Med. 350: 379-392, 2004.
120. Carney, D.N. Lung cancer-time to move on from chemotherapy. N. Engl. J. Med. 346: 126-128, 2002.
121. Kasai, H., J.T. Allen, R.M. Mason, T. Kamimura, and Z. Zhang. TGF-b1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir. Res. 6: 56, 2005.
122. Keshamouni, V.G., G. Michailidis, C.S. Grasso, S. Anthwal, J.R. Strahler, A. Walker, D.A. Arenberg, R.C. Reddy, S. Akulapalli, V.J. Thannickal, T.J. Standiford, P.C. Andrews, and G.S. Omenn. Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J. Proteome Res. 5: 1143-1154, 2006.
123. Cordenonsi, M., S. Dupont, S. Maretto, A. Insinga, C. Imbriano, and S. Piccolo. Links between tumor suppressors: p53 is required for TGF-b gene responses by cooperating with Smads. Cell 113: 301-314, 2003.
124. Shintani, Y., M. Maeda, N. Chaika, K.R. Johnson, and M.J. Wheelock. Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-b signaling. Am. J. Respir. Cell. Mol. Biol. 38: 95-104, 2008.
125. Lu, Z., S. Ghosh, Z. Wang, and T. Hunter. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of b-catenin, and enhanced tumor cell invasion. Cancer Cell 4: 499-515, 2003.
126. Masuda, A., M. Kondo, T. Saito, Y. Yatabe, T. Kobayashi, M. Okamoto, M. Suyama, and T. Takahashi. Establishment of human peripheral lung epithelial cell lines (HPL1) retaining differentiated characteristics and responsiveness to epidermal growth factor, hepatocyte growth factor, and transforming growth factor b1. Cancer Res. 57: 4898-4904, 1997.
127. Blanco, D., S. Vicent, E. Elizegi, I. Pino, M.F. Fraga, M. Esteller, U. Saffiotti, F. Lecanda, and L.M. Montuenga. Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis. Lab Invest. 84: 999-1012, 2004.
128. Powell, D.W., R.C. Mifflin, J.D. Valentich, S.E. Crowe, J.I. Saada, and A.B. West. Myofibroblasts. I. Paracrine. cells important in health and disease. Am. J. Physiol. 277: C1-9, 1999.
129. Balkwill, F. and A. Mantovani. Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001.
130. Bhowmick, N.A., A. Chytil, D. Plieth, A.E. Gorska, N. Dumont, S. Shappell, M.K. Washington, E.G. Neilson, and H.L. Moses. TGF-b signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303: 848-851, 2004.
131. Cheng, N., N.A. Bhowmick, A. Chytil, A.E. Gorksa, K.A. Brown, R. Muraoka, C.L. Arteaga, E.G. Neilson, S.W. Hayward, and H.L. Moses. Loss of TGF-b type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-b-, MSP-and HGF-mediated signaling networks. Oncogene 24: 5053-5068, 2005.
132. Nakamura, T., K. Matsumoto, A. Kiritoshi, and Y. Tano. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res. 57: 3305-3313, 1997.
133. Gmyrek, G.A., M. Walburg, C.P. Webb, H.M. Yu, X. You, E.D. Vaughan, G.F. Vande Woude, and B.S. Knudsen. Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor. Am. J. Pathol. 159: 579-590, 2001.
134. Beviglia, L., K. Matsumoto, C.S. Lin, B.L. Ziober, and R.H. Kramer. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression. Int. J. Cancer 74: 301-309, 1997.
135. Masuya, D., C. Huang, D. Liu, T. Nakashima, K. Kameyama, R. Haba, M. Ueno, and H. Yokomise. The tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients. Br. J. Cancer 90: 1555-1562, 2004.
136. Lewis, M.P., K.A. Lygoe, M.L. Nystrom, W.P. Anderson, P.M. Speight, J.F. Marshall, and G.J. Thomas. Tumour-derived TGF-b1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br. J. Cancer 90: 822-832, 2004.
137. Joseph, H., A.E. Gorska, P. Sohn, H.L. Moses, and R. Serra. Overexpression of a kinase-deficient transforming growth factor-b type II receptor in mouse mammary stroma results in increased epithelial branching. Mol. Biol. Cell 10: 1221-1234., 1999.
138. Wynn, T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214: 199-210, 2008.
139. Iwano, M., D. Plieth, T.M. Danoff, C. Xue, H. Okada, and E.G. Neilson. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110: 341-350, 2002.
140. Yang, J. and Y. Liu. Blockage of tubular epithelial to myofibroblast transition by hepato-cyte growth factor prevents renal interstitial fibrosis. J. Am. Soc. Nephrol. 13: 96-107, 2002.
141. Kalluri, R. and E.G. Neilson.Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112: 1776-1784, 2003.
142. Saika, S., S. Kono-Saika, Y. Ohnishi, M. Sato, Y. Muragaki, A. Ooshima, K.C. Flanders, J. Yoo, M. Anzano, C.Y. Liu, W.W. Kao, and A.B. Roberts. Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am. J. Pathol. 164: 651-663, 2004.
143. Schurch, W., T.A. Seemayer, and G. Gabbiani.: The myofibroblast a quarter century after its discovery. Am. J. Surg. Pathol. 22: 141-147, 1998.
144. Phan, S.H. The myofibroblast in pulmonary fibrosis. Chest 122: 286S-289S, 2002.
145. Singh, S.R. and I.P. Hall. Airway myofibroblasts and their relationship with airway myocytes and fibroblasts. Proc. Am. Thorac. Soc. 5: 127-132, 2008.
146. Direkze, N.C., K. Hodivala-Dilke, R. Jeffery, T. Hunt, R. Poulsom, D. Oukrif, M.R. Alison, and N.A. Wright. Bone marrow contribution to tumor-associated myofi-broblasts and fibroblasts. Cancer Res. 64: 8492-8495, 2004.
147. Forbes, S.J., F.P. Russo, V. Rey, P. Burra, M. Rugge, N.A. Wright, and M.R. Alison. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126: 955-963, 2004.
148. Ebihara, Y., M. Masuya, A.C. Larue, P.A. Fleming, R.P. Visconti, H. Minamiguchi, C.J. Drake, and M. Ogawa. Hematopoietic origins of fibroblasts: II. In vitro studies of fibroblasts, CFU-F, and fibrocytes. Exp. Hematol. 34: 219-229, 2006.
149. Quan, T.E., S.E. Cowper, and R. Bucala. The role of circulating fibrocytes in fibrosis. Curr. Rheumatol. Rep. 8: 145-150, 2006.
150. Willis, B.C., R.M. duBois, and Z. Borok. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc. Am. Thorac. Soc. 3: 377-382, 2006.
151. Zeisberg, E.M., O. Tarnavski, M. Zeisberg, A.L. Dorfman, J.R. McMullen, E. Gus-tafsson, A. Chandraker, X. Yuan, W.T. Pu, A.B. Roberts, E.G. Neilson, M.H. Sayegh, S. Izumo, and R. Kalluri. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13: 952-961, 2007.
152. Hu, B., Z. Wu, and S.H. Phan. Smad3 mediates transforming growth factor-b-induced b-smooth muscle actin expression. Am. J. Respir. Cell Mol. Biol. 29: 397-404, 2003.
153. Reubinoff, B.E., M.F. Pera, C.Y. Fong, A. Trounson, and A. Bongso. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18: 399-404, 2000.
154. Smith, A.G. Embryo-derived stem cells: of mice and men. Annu. Rev. Cell Dev. Biol. 17: 435-462, 2001.
155. Spencer, H.L., A.M. Eastham, C.L. Merry, T.D. Southgate, F.Perez-Campo, F. Soncin, S. Ritson, R. Kemler, P.L. Stern, and C.M. Ward. E-cadherin inhibits cell surface localization of the pro-migratory 5T4 oncofetal antigen in mouse embryonic stem cells. Mol. Biol. Cell 18: 2838-2851, 2007.
156. Eastham, A.M., H. Spencer, F. Soncin, S. Ritson, C.L. Merry, P.L. Stern, and C.M. Ward. Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res. 67: 11254-11262, 2007.
157. Cavallaro, U. and G. Christofori. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 4: 118-132, 2004.
158. Mani, S.A., W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, A.Y. Zhou, M. Brooks, F. Reinhard, C.C. Zhang, M. Shipitsin, L.L. Campbell, K. Polyak, C.
159. Lobo, N.A., Y. Shimono, D. Qian, and M.F. Clarke. The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol. 23: 675-699, 2007.
160. Dalerba, P. and M.F. Clarke. Cancer stem cells and tumor metastasis: first steps into uncharted territory. Cell Stem Cell 1: 241-242, 2007.
161. Karnoub, A.E., A.B. Dash, A.P. Vo, A. Sullivan, M.W. Brooks, G.W. Bell, A.L. Richardson, K. Polyak, R. Tubo, and R.A. Weinberg. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563, 2007.
162. Thiery, J.-P. and J.P. Sleeman. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell. Biol. 7: 131-142, 2006.
163. Prindull, G. Hypothesis: cell plasticity, linking embryonal stem cells to adult stem cell reservoirs and metastatic cancer cells? Exp. Hematol. 33: 738-746, 2005.
164. Ben-Porath, I., M.W. Thomson, V.J. Carey, R. Ge, G.W. Bell, A. Regev, and R.A. Weinberg. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40: 499-507, 2008.
165. Ullmann, U., P. In't Veld, C. Gilles, K. Sermon, M. De Rycke, H. Van de Velde, A. Van Steirteghem, and I. Liebaers. Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions. Mol. Hum. Reprod. 13: 21-32, 2007.
166. Fischer, A.N., E. Fuchs, M. Mikula, H. Huber, H. Beug, and W. Mikulits. PDGF essentially links TGF-b signaling to nuclear b-catenin accumulation in hepatocellular carcinoma progression. Oncogene In press, 2006.
167. Tarin, D., E.W. Thompson, and D.F. Newgreen. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res. 65: 5996-6000; discussion 6000-1, 2005.
168. Christiansen, J.J. and A.K. Rajasekaran. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 66: 8319-8326, 2006.
169. Wicki, A., F. Lehembre, N. Wick, B. Hantusch, D. Kerjaschki, and G. Christofori. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9: 261-272, 2006.
170. Trimboli, A.J., K. Fukino, A. de Bruin, G. Wei, L. Shen, S.M. Tanner, N. Creasap, T.J. Rosol, M.L. Robinson, C. Eng, M.C. Ostrowski, and G. Leone. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res. 68: 937-945, 2008.